FDA Marks PANRAY's THEOLIXIR Oral Elixir as Discontinued (ANDA084559)

The U.S. Food and Drug Administration (FDA) has recorded the status of product THEOLIXIR under application number ANDA084559. THEOLIXIR is an oral elixir (route: ORAL) marketed by sponsor PANRAY. The product contains the active ingredient THEOPHYLLINE at a strength of 80 mg per 15 mL. According to the FDA filing, the marketing status of THEOLIXIR is listed as discontinued. No reference drug or reference standard is associated with this filing.